Observational × Endometrial Neoplasms × Genitourinary × Clear all ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Recruiting
105 enrolled
ELEPHAS-04
Recruiting
324 enrolled
DP-04
Recruiting
100 enrolled
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
Recruiting
60 enrolled
iCaRe2
Recruiting
999,999 enrolled
CAMPERR
Recruiting
7,000 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
ORACLE
Recruiting
2,020 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
EPRIMM
Completed
18 enrolled
INSPIRE
Recruiting
5,350 enrolled
MIFADORESOL
Completed
100 enrolled
WiZen
Completed
670,000 enrolled
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
Unknown
200 enrolled
Continuation of Follow-up of DES-Exposed Cohorts
Completed
10,805 enrolled
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Unknown
2,000 enrolled
N1
Terminated
23 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Completed
1,262 enrolled 14 charts